These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3369099

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Seizures and transient blindness following intravenous pulse methylprednisolone in children with primary glomerulonephritis.
    Bettinelli A, Paterlini G, Mazzucchi E, Giani M.
    Child Nephrol Urol; 1991; 11(1):41-3. PubMed ID: 1868481
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic glomerulonephritis with imuran].
    Kämpfen P, Hodler J.
    Schweiz Med Wochenschr; 1970 Dec 05; 100(49):2093-100. PubMed ID: 5495326
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efficacy and problems of the pulse therapy and alternate-day schedule].
    Miyawaki S, Hashimoto K, Ofuji T.
    Nihon Rinsho; 1984 Nov 05; 42(11):2509-15. PubMed ID: 6397616
    [No Abstract] [Full Text] [Related]

  • 8. Macrohematuria with electron-dense deposits in a 14-year-old boy with minimal change nephrotic syndrome.
    Filler G, Robb I, Carpenter B.
    Pediatr Nephrol; 2001 Jan 05; 16(1):91-3; discussion 94-6. PubMed ID: 11198614
    [No Abstract] [Full Text] [Related]

  • 9. Autoimmune thyroiditis and vitiligo in a child with minimal change nephrotic syndrome.
    Kuzmanovska DB, Shahpazova EM, Kocova MJ, Gruevska SJ, Petrushevska G.
    Pediatr Nephrol; 2001 Dec 05; 16(12):1137-8. PubMed ID: 11793116
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Squamous cell lung cancer with minimal-change nephrotic syndrome].
    Yamagata T, Akamatsu K, Kuroda M, Yamagata Y, Nisimoto T, Nakanishi H, Habu Y, Ikeda T, Mimura K, Yukawa S.
    Nihon Kokyuki Gakkai Zasshi; 1998 Dec 05; 36(12):1032-7. PubMed ID: 10064957
    [Abstract] [Full Text] [Related]

  • 13. [Current therapeutic possibilities in chronic idiopathic glomerulonephritis].
    Ponticelli C, Fogazzi GB.
    Minerva Urol Nefrol; 1985 Dec 05; 37(1):9-12. PubMed ID: 3901338
    [No Abstract] [Full Text] [Related]

  • 14. Characterization and significance of urinary fibrin degradation products.
    Cortes P, Potter EV, Kwaan HC.
    J Lab Clin Med; 1973 Sep 05; 82(3):377-89. PubMed ID: 4199524
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.
    Matsumoto K, Kanmatsuse K.
    Clin Nephrol; 2001 Apr 05; 55(4):269-74. PubMed ID: 11334311
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.